Sacral wound dressing
Latest Bristol-Myers Squibb Company Patents:
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Method of purity determination by capillary electrophoresis
- Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof
- ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
- Supramolecular filamentous assemblies for protein purification
Description
The broken line showing of sacral wound dressing is included for the purpose of illustrating stitching and forms a part of the claimed design.
Claims
We claim the ornamental design for the sacral wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D607112
Type: Grant
Filed: Dec 5, 2007
Date of Patent: Dec 29, 2009
Assignee: Bristol-Myers Squibb Company (Skillman, NJ)
Inventors: Jan Rogers (Flintshire), Bryony Lee (Flintshire)
Primary Examiner: Holly H Baynham
Assistant Examiner: Michelle E Wilson
Attorney: John M. Kilcoyne
Application Number: 29/298,416
Type: Grant
Filed: Dec 5, 2007
Date of Patent: Dec 29, 2009
Assignee: Bristol-Myers Squibb Company (Skillman, NJ)
Inventors: Jan Rogers (Flintshire), Bryony Lee (Flintshire)
Primary Examiner: Holly H Baynham
Assistant Examiner: Michelle E Wilson
Attorney: John M. Kilcoyne
Application Number: 29/298,416
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)